A detailed history of Rubric Capital Management LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rubric Capital Management LP holds 14,400,000 shares of ADPT stock, worth $63.6 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares
14,400,000
Previous 14,000,000 2.86%
Holding current value
$63.6 Million
Previous $50.7 Million 45.48%
% of portfolio
2.05%
Previous 1.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.37 - $5.12 $1.35 Million - $2.05 Million
400,000 Added 2.86%
14,400,000 $73.7 Million
Q2 2024

Aug 13, 2024

BUY
$2.34 - $3.96 $8.19 Million - $13.9 Million
3,500,000 Added 33.33%
14,000,000 $50.7 Million
Q1 2024

May 10, 2024

BUY
$2.88 - $4.8 $22 Million - $36.7 Million
7,637,271 Added 266.78%
10,500,000 $33.7 Million
Q4 2023

Feb 13, 2024

BUY
$3.46 - $5.33 $9.91 Million - $15.3 Million
2,862,729 New
2,862,729 $14 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $631M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.